Vext Science, Inc.
VEXTF
$0.19
$0.013.94%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -9.58% | 5.18% | 34.67% | 40.98% | 59.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.58% | 5.18% | 34.67% | 40.98% | 59.10% |
| Cost of Revenue | -36.58% | -28.50% | 29.00% | 73.36% | 24.18% |
| Gross Profit | 37.73% | 142.34% | 56.04% | 0.03% | 213.51% |
| SG&A Expenses | 19.59% | 35.80% | 17.84% | 1.03% | 25.15% |
| Depreciation & Amortization | -10.59% | 10.32% | 21.39% | 6.50% | -31.43% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.37% | -10.52% | 26.75% | 37.55% | 13.92% |
| Operating Income | 265.41% | 100.00% | 1.18% | -13.63% | 87.31% |
| Income Before Tax | -125.00% | 81.92% | -25.82% | -4.97% | 105.84% |
| Income Tax Expenses | -85.71% | 211.66% | -25.54% | -1.67% | 1,471.65% |
| Earnings from Continuing Operations | 78.69% | 73.25% | -14.56% | -5.29% | 66.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.69% | 73.25% | -14.56% | -5.29% | 66.33% |
| EBIT | 265.41% | 100.00% | 1.18% | -13.63% | 87.31% |
| EBITDA | 25.32% | 117.39% | 24.31% | -1.11% | 1,868.74% |
| EPS Basic | 78.33% | 73.33% | -14.52% | -3.92% | 66.48% |
| Normalized Basic EPS | 118.18% | 72.34% | 38.95% | 5.56% | 90.68% |
| EPS Diluted | 78.33% | 73.33% | -14.78% | -3.92% | 66.48% |
| Normalized Diluted EPS | 118.18% | 72.34% | 38.95% | 3.77% | 90.68% |
| Average Basic Shares Outstanding | 0.04% | 0.08% | 0.10% | 0.84% | 0.87% |
| Average Diluted Shares Outstanding | 0.04% | 0.08% | 0.10% | -0.42% | 0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |